Suchergebnisse - "Bowling, Gartrell C"

PubPharm (4)

1

Hematological Toxicities with PARP Inhibitors in Prostate Cancer : A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials

enthalten in: Cancers | 2023

von Bowling, G. | Swargaloganathan, P. | Heintz, C. | +4

2

Emerging Developments in ETS-Positive Prostate Cancer Therapy

enthalten in: Molecular cancer therapeutics | 2023

von Bowling, G. | Rands, M. | Dobi, A. | +1

3

Darolutamide in Metastatic Prostate Cancer

enthalten in: The New England journal of medicine | 2022

von Bowling, G. | Dimitrakoff, J.

CommentOn: N Engl J Med. 2022 Mar 24;386(12):1132-1142. - PMID 35179323

4

PSMA PET in Prostate Cancer-A Biomarker or a Surrogate End Point?

enthalten in: JAMA oncology | 2022

von Bowling, G. | Dimitrakoff, J.

CommentOn: JAMA Oncol. 2021 Nov 01;7(11):1635-1642. - PMID 34529005

1
[1]